THE CONTRIBUTION OF PENELOPE KOKKINIDES IN INNOVACARE HEALTH.

Ms. Penelope Kokkinides was the operating officer at the Innovacare health solutions from 2006 to 2012. She also served in Aveta Inc as the chief operating officer. From 2008 she served at Touchstones as the chief operating officer. For over two decades now she has the experience of managing healthcare and has specialized in government programs. Before joining Aveta, she served as the corporate vice president for care and management and disease management at the Americhoice which is a business unit of united health group, here she was vital in the development and implementation of the healthcare model.

 

Penelope Kokkinides graduated from the Binghamton University with the B.S in biological sciences and classical languages, and she later joined New York University for her first masters in social work, she finally did her second masters at Columbia University where she specialized with public health. She did language fluency in Greek.

 

Invited in Whitehouse Penelope Kokkinides was among seven other women invited to a panel by united states president Donald Trump to sit at a roundtable to discuss about health affairs. During the meeting she mentioned the importance of fund increment for Medicare as from the year 2011 there was federal funding cut in Puerto Rico for Medicare which dropped the advantage by an annual amount of about $1 billion an amount that is significantly inappropriate to the reductions in the united states.

 

Penelope Kokkinides recommended that fixing of the cuts be done since it’s not only an important thing to do, but it is a responsible thing because when the Medicaid system collapses in Puerto Rico there will be many people who will be forced to migrate from the island headed for the states where their Medicaid cost may have gone higher three to four times. Days after meeting president Trump released a notice, and that final notice provided favorable changes for the Puerto Rico healthcare systems.

 

Innovacare, Inc gives health services in Puerto Rico and manages other two government Medicaid plans within the area which brings broad benefit coverage through a structured care model. Invacare also is dedicated to offering the island with accredited health plans and world-class healthcare services through creating sustainable models of monitored care, cost friendly, innovative and integrated technology. To sum all this Ms. Penelope Kokkinides presence in the healthcare systems for over 20 years has brought massive changes that have benefited both Puerto Ricans and the United States.

 

Jim Tananbaum, Chief Executive Officer and Founder of Foresite Capital

Jim Tananbaum serves as the Chief Executive Officer and Founder of Foresite Capital. In 2011, Jim Tananbaum Foresite Capital founded Foresite Capital, a private equity healthcare firm that specializes in the identification of emerging leaders in the healthcare industry.

About Foresite Capital

The headquarters of Foresite Capital are in San Francisco. Furthermore, in New York, the Healthcare firm also has an additional office. Foresite Capital invests in the top most innovative healthcare companies. Also, the company offers growth capital to emerging healthcare providers in the private and public sectors. The investments are done on enterprises that have disruptive last-stage services as products. The company is valued at about 1.1 billion dollars in terms of assets. Intarcia is Foresite’s latest and largest investment. Intarcia is a type II diabetes implant that helps patients to control their diabetes and weight.

About Jim Tananbaum

Before establishing Foresite Capital, Jim was a co-founder of two healthcare investment practices and two biopharmaceutical companies. Jim Tananbaum has over 25years of experience in the healthcare sector where he has served at management positions at GelTex and Theravance Pharmaceuticals. In 1998, GelTex was acquired for 1.6 billion dollars, and its lead drug called Renzela had an excess revenue rate of 200 million dollars. He is also a founding partner at Sierra Ventures and Prospect Venture Partners II and III. Check out his About.me page

In 1998, Jim Tananbaum obtained an M. D and an M.B.A from Havard Business School. Jim also majored in Math and computer science/electrical engineering from Yale University. Jim holds an M.S. from the Massachusetts Institute of Technology. He has productive and long-term relationships with leading academicians and has been mentored by Rick Levin from Yale, George Whitesides from Harvard and Roy Vagelos from Theravance. Jim continues to collaborate with these leading academicians and entrepreneurs in a bid to develop new great insights in the healthcare industry.

Jim Tananbaum has appeared on the Midas List for three years straight. This list features the top hundred investors. Jim has undertaken various major investments in the health sector including two diabetes treatment unicorns known as Juno Therapeutics and Intarcia Therapeutics.

See more: https://ideamensch.com/jim-tananbaum/